Severe adverse events in the Italian and Stockholm I pertussis vaccineclinical trials.

xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns="http://www.w3.org/TR/REC-html40"> Severe adverse events in the Italian and Stockholm I pertussis vaccine clinical trials.

http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9272334&form=6&db=m&Dopt=b

 

Dev Biol Stand 1997;89:77-81

Related Articles, Books, LinkOut


Severe adverse events in the Italian and Stockholm I pertussis vaccine clinical trials.

Ciofi degli Atti ML, Olin P.

Istituto Superiore di Sanita, Rome, Italy.

The rates of severe side reactions observed in Stockholm I and Italian Trials are reported. Children vaccinated with the same DTPwc in both trials experienced high fever and persistent crying more frequently than in any other group, while similar rates for all the severe side reactions were observed among DTaPs and DT vaccines. Recipients of different DTaP vaccines showed similar rates of severe reactions, which did not differ from recipients of DT vaccines, either in Sweden or Italy.

Publication Types:

·         Clinical trial

·         Randomized controlled trial


PMID: 9272334 [PubMed - indexed for MEDLINE

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.